Please assess the completion status of the following clinical trial:

Trial Title: TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients presenting~a. to the neurologist for evaluation of stroke or TIA (Symptomatic) with: i. Symptomatic patients with plaque ≥70% in at least one carotid artery that would be implicated as the source of embolus responsible for the stroke/TIA. b. or to the vascular surgeon for CEA (Asymptomatic) with: i. asymptomatic patients with a luminal stenosis of ≥70% in at least one carotid artery (stable plaque) referred for CEA ii. age-matched by deciles to symptomatic patients~Exclusion Criteria:~1. stroke due to atrial fibrillation,~2. preexisting carotid stents in the artery of interest,~3. renal dysfunction defined as glomerular filtration rate (GFR) \<40ml/min,~4. allergy to gadolinium based contrast agents,~5. Volunteers who have had four or more prior previous gadolinium contrast scans~6. metal implants incompatible with MRI or other condition that prohibits MRI,~7. pregnancy,~8. inability to provide informed consent and~9. age ≤18 years.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- [F-18] RDG-K5 (Type: EXPERIMENTAL): PET/CT Imaging with administration of \[F-18\] RGD-K5

Based on this trial design, predict the completion outcome and termination type (if applicable).